The International Consortium on Meningiomas (ICOM) – Tuesday, May 21, 2024

March 21, 2024

ICOM – Tues May 21The International Consortium on Meningiomas (ICOM) is hosting a scientific day on Tuesday, May 21 as part of University of Toronto Division of Neurosurgery 100 Years and CNSF 2024 Congress.

Led by Dr. Gelareh Zadeh, this consortium was formed to increase awareness for this understudied disease and conduct cutting-edge meningioma research through international and multidisciplinary collaboration. This meeting’s program will feature updates on ongoing collaborative research as well as a practical overview of modern meningioma management, with themes including surgical management, biomarkers, clinical trials updates and more. We will also host a molecular tumour board where complex cases are reviewed by an expert multidisciplinary panel with opportunity for audience involvement. These sessions will be highly relevant to anyone involved in meningioma research or clinical care and all are welcome to attend.

Register for course HERE

Submit an Abstract HERE

ICOM Agenda

Moderators: Michael Cusimano, Justin Wang

8:00 – 8:05 Overview of ICOM: Meningioma Consortium and 100th Anniversary of Neurosurgery

Gelareh Zadeh

8:05 – 8:20 Sex and Racial Disparities in Meningioma

Quinn T. Ostrom

8:20 – 8:35 Tumour Microenvironment of Meningioma

Christel Herold-Mende

8:35 – 8:50 Epigenomic drivers of Meningioma

Mark Youngblood

8:50 – 9:05 Metabolic Landscape of Aggressive Meningioma

Alex Landry

9:05 – 9:20 Discussion/Break

9:20 – 9:35 Predictive Signatures for Meningiomas

Akash J. Patel

9:35 – 9:50 Role of Radiotherapy for Meningioma

Justin Wang

9:50 – 10:05 Biomarkers of Radiation Response

David R. Raleigh

10:05 – 10:20 Role of Liquid Biopsy

Houtan Noushmehr

10:20 – 10:35 Update on EANO Guidelines for Molecular Testing, Biomarker Consortium

Susan Short

10:35 – 10:50 Discussion/Break

10:50 – 11:00 Health-related Quality of Life in Meningioma

Tobias Walbert

11:00 – 11:15 Development and Validation of a Quality of Life Questionnaire for Meningioma

Michael Cusimano

11:15 – 11:30 Neurocognitive, Psychological, and Functional Outcomes in Patients with Meningioma

Angela Sekely

11:30 – 11:45 International Tuberculum Sellae Meningioma Study

Michael W. McDermott

11:45 – 12:00 Role of Preoperative Embolization

Vitor Mendes Pereira

12:00 – 12:15 Endoscopic Anatomy From an ENT Perspective

Ian Witterick

12:15 – 1:00 Lunch

Moderators: Farshad Nassiri, Susan Short

1:00 – 2:00 Molecular Tumour Board

Speaker:  Michael Cusimano, Kate Drummond, Evanthia Galanis, Andrew Gao, Jorge-Christian Tonn, Derek Tsang

2:00 – 2:15 DOTATATE- PET and Theranostics of Meningioma: European Update

Joerg-Christian Tonn

2:15 – 2:30 Clinical Trial Design of Theranostics of Meningioma – North American Update

Erik P. Sulman

2:30 – 2:45 Alliance Trials and Opportunities: The Role of Umbrella Trials in Meningioma

Evanthia Galanis

2:45 – 3:00 Radiation versus Observation for Atypical Meningioma: update from the ROAM/EORTC1308 trial

Michael D. Jenkinson

3:00 – 3:15 Evaluating Immunohistochemical Surrogates for Meningioma Molecular Subtypes

P.J. Cimino

3:15 – 3:30 Outcomes in Grade 3 Meniningioma

Alexander Rebchuk

3:30 – 3:45 Updates on Molecular Pathology of Meningioma/WHO grading

Stephen Yip

3:45 – 4:00 Mutation Landscape of Meningioma Grade Progression

Kate Drummond

4:00 – 4:15 cIMPACT update

Felix Sahm

4:15 Discussion/ Closing Remarks

Speaker: Gelareh Zadeh